{"name":"Modus Therapeutics AB","slug":"modus-therapeutics-ab","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","status":"active","statusNote":"","leadDrug":"","leadIndication":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMiZEFVX3lxTE14UDQ2LW1ReE5PN2x2MFBmRHoxaDR6Mk9DeVRTTU00blIxcGhqb01Hc19EZE5pM2dlSHU0TUxLRUc2Vzd1cEdIRXVaWUlMWFhwZkczal8yV3drNkhOanFpNGUtLUo?oc=5","date":"2026-04-01","type":"pipeline","source":"GuruFocus","summary":"OSTO Stocks: Research Stocks from OSTO - GuruFocus","headline":"OSTO Stocks: Research Stocks from OSTO","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMisAFBVV95cUxQSnBJX095SXdLZ1ZpaG43YkloNmVPakI4czZsR3k0UENmR0dlTHYwalFiVUl1TmNOdWl4UGd1Mjh2bGwxRW40UjItTmxiSnpZc1hPNkw5bnVqbFpibEc4S2haSWtvMVVJZnZtdXpJUkJEU25xZnFkNUs5MS1hYmdLYW85VzNGUjJPZktZWjZ3MWJFc2hZemNPaDRzZDVSNUxCWUQwandHY1RveWpCWDJWbQ?oc=5","date":"2025-12-10","type":"trial","source":"PharmaTimes","summary":"Modus Therapeutics advances sevuparin study in chronic kidney disease with anemia - PharmaTimes","headline":"Modus Therapeutics advances sevuparin study in chronic kidney disease with anemia","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi-AFBVV95cUxPSjhKdlNwY01UVUlZWXVTejVSMGhUaFNPaDBvZWpEWFZTUmR0cjlmNU4xc0N2dUNRanFMaE5hY3g4M2ZveEZzTU8wUm0xRVR1YzRCNkxsZWFxdjM0U05UMm5fdFZ6a09EQnFpTllRRC1GeUszUmFIMnpOY1ZxdVRPZV95clI4bEhDZHExY3c3bTJvNTJHS3NsMko5YXFrWjlHRnFaR0dxZ2lKYkswVlR4aVhCT0F6aHNydldlS3dGR3ljSjYzUjhRbjRKMDliVjFUMHpFM1RZaEcySUNmVFpDOHNyWGctV1hqdWFrbk02cHItcUR3U0NaMNIB_gFBVV95cUxQQW9fcVEyR0pNNW83NzJYSl82MTVZMEpuRVZ5V3VhTHJDcExPQllpSTZSOXhwSVpjZU1TV2xSOWdsMmloNUh4QVZGdzViX0hpQkNBQ0NfVXRXaXNjVmlDZWIxdmtLbjZMNGhIZGNFbnNKYUJHaUsyRmdPakhUYUpvdUlPRGxaY0kyZXJlamFNQXBTS3NNRXFEaURnV0ZkcVdYQ3RWSm5UdFp1MTNJQW8zUy1FdFVkOWlmUkJMYy03a2hHLVdhby04S1ZQckZ2SFlSZzBuTEI3X0E3SzFsd1psekNBTFZzdWxDTUxHSnZjRFZaOFg5UnpEMGlrVC1rQQ?oc=5","date":"2025-12-09","type":"earnings","source":"simplywall.st","summary":"Modus Therapeutics Holding AB (publ)'s (STO:MODTX) Shift From Loss To Profit - simplywall.st","headline":"Modus Therapeutics Holding AB (publ)'s (STO:MODTX) Shift From Loss To Profit","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMizAFBVV95cUxPeVA1SWo1bjVPemRrdU03M0VZUlN1UzBQaVBWam5IMWVKOXZYOVc5ZEFDUUZoZ09fd1M3VTd2U1dPbW5ZZGNZN3pYb252bXUtdHNzdklGSlZOWHIwNmRYQ1JxUmV4SUt2V1VyejFkZXlQbVRSdmZEeDNHeDhQbXNmOGtFYUE4a2I4ZXV0VzR4TXhmLUU5eW1pSXhrU3BmN0dNRzh4M3ZnQ2dyNjdQVVdaaW02dDZXSnlCOXJvNWE3ODVmOXU0M0VTUE44M0Y?oc=5","date":"2025-09-18","type":"pipeline","source":"Business Wire","summary":"Neumirna Therapeutics Appoints Ellen K. Donnelly as Chief Executive Officer - Business Wire","headline":"Neumirna Therapeutics Appoints Ellen K. Donnelly as Chief Executive Officer","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMicEFVX3lxTE9OdWM5NThWSXFQQThTTzJwWkpBdFhMcl8wOVJjcVpOUkJVcjc3MGFPM3lpdWV5dTFKbGNkc2tQOUp5SUZBcHdPd1RUMVVvQndYVDhIMWRTdFlwZkp2Y3VTSXFrUlZBYWRMbVo2TVhEaVQ?oc=5","date":"2024-05-28","type":"pipeline","source":"Labiotech.eu","summary":"8 Swedish companies spearheading the country’s biotech scene - Labiotech.eu","headline":"8 Swedish companies spearheading the country’s biotech scene","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiV0FVX3lxTE03UXhzQ3VicXdxYjEwSWo5WktXWnRqY1o3amRIVUJLUHdWOFF2S185ZkE2MERKZ3J6RnUyVXVqLXhFdmRVUUxodEVlWFlRN05lSk1NY2d0MA?oc=5","date":"2021-06-18","type":"pipeline","source":"Yahoo Finance UK","summary":"Faron Pharmaceuticals Oy (FARON.HE) stock price, news, quote and history - Yahoo Finance UK","headline":"Faron Pharmaceuticals Oy (FARON.HE) stock price, news, quote and history","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMigwFBVV95cUxPVTYtcmVPaDdYMWZlRFNlejhGclpVSUE3REp3dmo1aHFmOTFudkN5SWtCcl9WUXBpa0wycGZ2SDJnejZxRlh6RkdFNnVOdlJSRm8tRTIzcVFVLVJZZGJrUlFIaXJhOXFTRzNGb1VWcHZvanA2bXVwSnBGWlhxLXdNR1NkRQ?oc=5","date":"2019-03-11","type":"pipeline","source":"European Biotechnology Magazine","summary":"Mats Blom joins Modus as CFO - European Biotechnology Magazine","headline":"Mats Blom joins Modus as CFO","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiVkFVX3lxTE9OTkZPRGozZEItUUh0TEg3MXpHd2c1czBKcTdDNUliWHU1Y21zbkl5T0FZQkg4SVBWaExHNWpudFljUDM2RHc4Q0tYU093RjF4RFRIcUNR?oc=5","date":"2017-06-10","type":"pipeline","source":"Yahoo! Finance Canada","summary":"Camurus AB (publ) (CAMX.ST) Stock Price, News, Quote & History - Yahoo! Finance Canada","headline":"Camurus AB (publ) (CAMX.ST) Stock Price, News, Quote & History - Yahoo! Finance Canada","sentiment":"neutral"}],"patents":[],"drugCount":0,"phaseCounts":{},"enrichmentLevel":2,"visitCount":2,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}